Article Sidebar

Submitted
May 8, 2021
Published
May 8, 2021
Download
PDF
Statistic
Read Counter : 71 Download : 45

Main Article Content

Abstract

Background


India has the largest drug consuming population in the world. Adverse drug reactions (ADR) are commonly encountered in daily practice, many of which are preventable .


Objective


To evaluate the knowledge, attitude and practice of ADR reporting and Pharmacovigilance concept among healthcare professionals.


Materials and Methods


It was a cross-sectional, questionnaire based survey conducted by the staff of the Department of Pharmacology at Dr.B.R.Ambedkar Medical College and Hospital, Bangalore in March 2017. 92 doctors participated in this study. Statistical analysis


Collected data was analyzed by frequency, percentage and mean using the statistical software SPSS version13.0


Results


98% of respondents were aware of the existence of suspected ADR reporting system in India. 54.6% of respondents were of the opinion that non availability of reporting forms discouraged them from ADR reporting. All respondents were of the opinion that ADR reporting system would benefit patient care. 50( 54.3% )of respondents have never even attended any Continuing Medical Education (CME) programme on ADRs, which shows that there is lack of awareness creating programs stressing on the importance of ADR reporting.


Conclusion


This study revealed that though majority of the health-care professionals had good knowledge and positive attitude about Pharmacovigilance, the actual practice of ADR reporting was unsatisfactory.

Keywords

Adverse drug reaction Knowledge Pharmacovigilance Attitude Spontaneous reporting

Article Details

How to Cite
Veena DR, & Shanmukananda P. (2021). Knowledge, attitude and practice of adverse drug reaction reporting and pharmacovigilance among healthcare professionals in a tertiary care teaching hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics, 7(3), 233-238. https://doi.org/10.61096/ijrpp.v7.iss3.2018.233-238
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Mc.Donell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 36, 2002, 1331-6.
  2. [2]. WHO. International Drug Monitoring: The Role of the Hospital. Geneva, Switzerland: WHO; Technical Report Series No 425, 1966.
  3. [3]. Haile DB, Ayen WY, Tiwari P. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India.Ethiop J Health Sci. 23(1), 2013, 39-48.
  4. [4]. Wu W, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. American Journal of Health-System Pharmacy. 60(3), 2003, 253-9.
  5. [5]. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital-their severity and cost involved. Pharmacoepidemiol Drug Saf. 2, 2003, 687-92.
  6. [6]. Pirmohamed, M, James S, Meakin S, Green C, Scott AK, Walley TJ. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 329, 2004,15
  7. [7]. Kharkar M, Bowalekar S. Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards ad-verse drug reaction (ADR) reporting. Per-spect Clin Res.3, 2012, 90-4.
  8. [8]. Thomas TM, Udaykumar P, Scandashree K. Knowledge, attitude and practice of adverse drug reaction reporting among doctors in a tertiary health care centre in South India. Int J Pharmacol and Clin Sci. 2, 2013, 82-8.
  9. [9]. Komaram RB and Dhar M. A study on assessment of knowledge, attitude and practice regarding pharmacovigilance amonghealthcare professionals in a tertiary care hospital, Andhra Pradesh. Int J Pharm Sci Res. 7(12), 2016, 5082-87.
  10. [10]. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Pharmacol. 9, 2009, 14.
  11. [11]. Okezie EO, Olufunmilayo F. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf .17, 2008. 517-22.